The suppression of malarial parasitaemia by pyrimethamine in combination with dapsone or sulphormethoxine.
D000293:Adolescent; D000962:Antimalarials / Q000627:therapeutic use*; D001769:Blood / Q000382:microbiology; D002648:Child; D002986:Clinical Trials as Topic; D003622:Dapsone / Q000627:therapeutic use*; D004926:Escherichia coli / Q000302:isolation & purification; D005243:Feces / Q000382:microbiology; D006400:Hematocrit; D006801:Humans; D007958:Leukocyte Count; D008288:Malaria / Q000188:drug therapy*; D010963:Plasmodium falciparum / Q000302:isolation & purification; D011725:Pyridines / Q000627:therapeutic use*; D011739:Pyrimethamine / Q000627:therapeutic use* / Q000652:urine; D013163:Splenomegaly / Q000188:drug therapy; D013449:Sulfonamides / Q000627:therapeutic use*
D000962:Antimalarials; D011725:Pyridines; D013449:Sulfonamides; D003622:Dapsone; D011739:Pyrimethamine